The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Maizel Ari since 2026.
This trader's CIK number is 2042289.
At the time of last reporting, Maizel Ari was the Chief Commercial Officer of Axsome Therapeutics, Inc.. (stock ticker symbol AXSM).
Also see all insider trading activities at Axsome Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | AXSM | 0 | $0 | 7,500 | $1,383,300 | 7,500 | $530,475 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-01-21 | AXSM | Sale | 7,500 | 184.44 | 1,383,300 |
| 2026-01-21 | AXSM | Option Ex | 7,500 | 70.73 | 530,475 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Maizel Ari (Chief Commercial Officer of Axsome Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.